analyst
NASDAQ · AXGN
AxoGen, Inc.
Healthcare · Medical - Devices
$43.39
Down-$0.03 (-0.07%)
Updated Sep 28, 2026, 10:27 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.38B
- P/E ratio
- -656.51
- Dividend yield
- 0.00%
- 52-week range
- $27.54 – $52.91
- Volume
- 1.22M
- Avg. volume
- 1.09M
Price performance · AXGN
AXGN price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Sep 25, 2026
AXGN closed at $43.39 after 19 trading sessions, down 14.52% for the selected period.
- Last close
- $43.39
- Period change
- -14.52%
- Period low
- $41.85
- Period high
- $50.76
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $43.61 | $44.68 | $43.05 | $43.39 | 1.22M |
| Sep 24, 2026 | $43.18 | $43.95 | $42.55 | $43.32 | 796.67K |
| Sep 23, 2026 | $44.54 | $44.84 | $43.25 | $43.32 | 1.25M |
| Sep 22, 2026 | $46.17 | $47.00 | $44.00 | $44.54 | 1.33M |
| Sep 21, 2026 | $44.82 | $46.58 | $44.32 | $45.93 | 1.2M |
| Sep 18, 2026 | $44.94 | $45.66 | $44.16 | $44.23 | 1.12M |
| Sep 17, 2026 | $45.91 | $46.89 | $45.07 | $45.285 | 831.48K |
| Sep 16, 2026 | $44.87 | $46.35 | $44.03 | $45.44 | 1.42M |
| Sep 15, 2026 | $43.85 | $45.46 | $43.51 | $44.97 | 1.4M |
| Sep 14, 2026 | $41.55 | $44.00 | $41.55 | $43.78 | 1.67M |
| Sep 11, 2026 | $42.48 | $42.59 | $39.62 | $42.16 | 3.48M |
| Sep 10, 2026 | $45.135 | $45.50 | $41.74 | $41.85 | 3.79M |
| Sep 9, 2026 | $46.21 | $48.105 | $46.00 | $47.27 | 728.8K |
| Sep 8, 2026 | $47.19 | $47.975 | $46.26 | $46.69 | 541.49K |
| Sep 4, 2026 | $46.73 | $48.385 | $46.29 | $48.28 | 550.07K |
| Sep 3, 2026 | $48.66 | $49.06 | $46.79 | $47.10 | 951.25K |
| Sep 2, 2026 | $50.15 | $51.50 | $47.83 | $48.30 | 789.92K |
| Sep 1, 2026 | $50.64 | $51.00 | $49.29 | $49.88 | 596.57K |
| Aug 31, 2026 | $50.97 | $51.18 | $49.63 | $50.76 | 878.14K |
Latest AXGN news
The latest Smart Investors Daily articles mentioning AXGN.
Stock researchResearch & News · SEC Filings
Loading stock research…